An AI-designed lung drug made patients' blood look years younger.
Insilico Medicine reported in Nature Biotechnology on Monday that its drug rentosertib lowered patients' predicted biological age. Six separate blood-protein age models from Harvard, Oxford and Peking University put treated patients up to 3.5 years younger. The authors call the result suggestive, not proof, because a treated lung could explain part of it.
Why it mattersAge-reversal claims usually come from supplement sellers, not from a placebo-controlled trial with published protein data. Forty-two patients over twelve weeks is still tiny, so read this as a signal, not a medicine.
Read in the app — free, in 9 languages
Related stories
Caltech is giving math teams $2 million of AI compute for a weekend.2026-09-07OpenAI's chief scientist says no lab should scale at full speed now.
2026-09-07OpenAI says it hit its own deadline for an AI research intern.
2026-09-07Psychiatrists call chatbot delusions real but not a diagnosis yet.
2026-09-06Seven minutes with Gemini beat a fact sheet at easing conspiracies.
2026-09-06